DXCM

DexCom, Inc.
Data: 2026-08-21

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Quick Stats
Aug 21, 2026

30.6

AI Score

EXTENDED

0.67

Volume Ratio

TBA

Next Earnings

18

+ve Days (30d)

12

-ve Days (30d)

DXCM Stock Summary

Last updated Aug 21, 2026

DXCM is currently trading at $92.34, positioned above its 200-day moving average of $69.32, indicating a long-term uptrend. The stock has a 52-week range of $54.11 to $92.56.

Technical Analysis: The 50-day moving average stands at $77.63, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 70.381, suggesting the stock is in overbought territory (bullish but caution advised).

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.242, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates DXCM at 30.6/100 with a EXTENDED recommendation.

DXCM (DexCom, Inc.) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 70.381
CMF (20) 0.242
ROC (10) 8.956
ADX (14) 34.838
Indicator Value
MACD (12,26,9) 4.219
AROONOSC (14) 71.429
WILLAMS %R (14) -2.101
MFI (14) 69.032
DXCM Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

DXCM Price vs Max Options Open Interest
DXCM Max Change In Options Open Interest

DXCM Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DXCM Daily Out of Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DXCM Daily In the Money Options - Sort by Max open Interest (near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DXCM Most Active Options by Volume(near term)

23rd August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

DexCom, Inc. is above both the 50 Day and 200 Day SMA which is considered Bullish.

DXCM Moving Averages Analysis

DexCom, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Aug 21, 2026

DexCom, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Aug 21, 2026

DXCM (DexCom, Inc.) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 90.0
20 85.3
30 81.59
50 77.63
100 71.49
200 69.32

DXCM Fundamental Analysis

P/E (Forward) 35.5872
P/E (Trailing) 35.5197
Market Cap ($) 34.0 billion
Earnings/Share ($) 2.54
Net Profit Margin (%) 0.2012
Dividend/Share ($) --
EPS Estimate Current Year ($) 2.6623
EPS Estimate Next Year ($) 3.1245
WallStreet Target Price ($) 94.12
Most Recent Quarter